Study | Country | Study design | Sample size | Trimester of Vitamin B12 | GDM diagnosis | Vitamin B12 and GDM | Folic acid/Vitamin B12 and GDM | Score | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
OR | 95%CI | P-value | OR | 95%CI | P-value | |||||||
Wang, 2020 [23] | China | case–control | NR1 | Third trimester | IADPSGC2 | 1.31 | 1.03–1.68 | 0.03 | - | - | - | 4 |
Sukumar, 2016 [22] | British | Retrospective case–control | 344 | Second trimester | WHO 19993 | 2.59 | 1.35–4.98 | 0.004 | - | - | - | 7 |
Krishnaveni, 2009 [17] | India | Prospective cohort-study | 785 | Third trimester | WHO 19993 | 2.00 | 1.1–3.6 | 0.02 | - | - | - | 7 |
Chen, 2021 [25] | China | Prospective cohort-study | 1058 | First trimester | IADPSGC2 | 1.54 | 1.41–1.68 | 0.002 | 0.98 | 0.97–0.99 | 0.009 | 7 |
Li, 2019 [26] | China | Cross-sectional | 406 | Third trimester | IADPSGC2 | 0.30 | 0.15–0.60 |  < 0.05 | 3.08 | 1.63–5.83 |  < 0.005 | 7 |
Lai, 2018 [18] | China, India, Malaysia | Cross-sectional | 913 | Second trimester | WHO 19993 | 0.81 | 0.68–0.97 | 0.02 | 1.97 | 1.05–3.68 | 0.034 | 7 |
Tan, 2020 [36] | Australia | Nested-cohort | 325 | Second trimester | WHO 20164 | 0.99 | 0.83–1.18 | 0.913 | 1.37 | 0.71–2.62 | 0.347 | 7 |
Sukumar, 2021 [24] | British | Prospective cohort-study | 4746 | First trimester | IADPSGC2 | 0.86 | 0.79–0.93 |  < 0.05 | 1.74 | 1.23–2.44 | 0.003 | 7 |
1.20 | 1.00–1.44 | 0.05 | ||||||||||
Krishnaveni, 2007 [35] | India | Prospective cohort-study | 654 | Third trimester | Carpenter-Coustan criteria5 | 1.90 | 0.98–3.68 | 0.057 | 4.8 | 1.45–15.84 | 0.01 | 4 |
Li, 2022 [27] | China | case–control | 1364 | Second trimester | IADPSGC2 | 0.80 | 0.65–0.98 | 0.033 |  | - | - | 7 |